WebApr 1, 2024 · Edarbi; Descriptions. Azilsartan is used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly. This can damage the blood vessels of the brain, heart, and kidneys ... WebAzilsartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing …
Takeda Pharmaceuticals North America, Inc.
Web491 is currently approved under the name Edarbi 20 mg, tablet in the EEA through a centralised procedure (EU/1/11/734/001) by the same MAH since 7 December 2011, as well as the United Sates, Canada, Mexico, Switzerland, Russia and several Asian, Middle Eastern and Latin countries. WebMar 18, 2024 · DESCRIPTION. Edarbyclor is a combination of azilsartan medoxomil (ARB; as its potassium salt) and chlorthalidone (thiazide-like diuretic).. Azilsartan medoxomil, a prodrug, is hydrolyzed to azilsartan in … egg with color
EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available …
WebJun 21, 2024 · Edarbyclor contains a combination of azilsartan and chlorthalidone. Azilsartan is an angiotensin II receptor blocker (sometimes called an ARB). … WebSep 11, 2013 · EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is a fixed-dose combination therapy for the treatment of hypertension that combines azilsartan medoxomil and chlorthalidone in a single tablet. Chlorthalidone reduces the amount of water in the body by increasing the flow of urine, which helps lower blood pressure. WebEdarbi is specifically indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents. Edarbi is supplied as a tablet for oral administration. The recommended initial dose in adults is 80 mg taken orally once daily. Edarbyclor is a combination of azilsartan and chlorthalidone, which produces diuresis. egg withcredentials